{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:40:05Z","timestamp":1790487605058,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2017,3,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Viscosupplementation has been widely used for the treatment of knee osteoarthritis. Because we found no well-controlled trial comparing single-injection regimens of hyaluronan for knee osteoarthritis, we compared the efficacy and safety of a single intra-articular injection of a novel cross-linked hyaluronan (HYA-JOINT Plus) with a single injection of Synvisc-One in patients with knee osteoarthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In a prospective, randomized, controlled, double-blind trial with a 6-month follow-up, 132 patients with knee osteoarthritis (Kellgren-Lawrence grade 2 or 3) were randomized to receive 1 intra-articular injection of 3 mL of HYA-JOINT Plus (20 mg\/mL) (n = 66) or 6 mL of Synvisc-One (8 mg\/mL) (n = 66). The primary outcome was the change from baseline in the visual analog scale (VAS) (0 to 100 mm) pain score at 6 months. Secondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC, Likert scale), Lequesne index, timed \u201cUp &amp; Go\u201d (TUG) test, single-limb stance (SLS) test, use of rescue analgesics, and patient satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 121 patients were available for the intention-to-treat analysis at 6 months. Both groups had a significant improvement in the VAS, WOMAC, and Lequesne index scores at each follow-up visit (p &lt; 0.001). Patients who received HYA-JOINT Plus experienced a significantly greater improvement in the VAS pain score at 1, 3, and 6 months compared with those treated with Synvisc-One (adjusted mean difference: \u221212.0, \u22128.5, and \u22126.6; p = 0.001, 0.033, and 0.045, respectively). There were no significant between-group differences in any of the secondary outcomes except the WOMAC stiffness scores at 6 months, which favored HYA-JOINT Plus treatment (p = 0.043). The TUG time did not change significantly in either group during the study (p &gt; 0.05), but the SLS time improved significantly in both the HYA-JOINT Plus and the Synvisc-One group (p = 0.004 and p = 0.022, respectively). No significant between-group differences were observed with respect to patient satisfaction or consumption of analgesics. No serious adverse events occurred following the injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A single injection of either HYA-JOINT Plus or Synvisc-One is safe and effective for 6 months in patients with knee osteoarthritis. HYA-JOINT Plus is superior to Synvisc-One in terms of reducing the VAS pain score at 1, 3, and 6 months and the WOMAC stiffness score at 6 months, with similar safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level I<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.16.00469","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T09:20:20Z","timestamp":1489569620000},"page":"462-471","source":"Crossref","is-referenced-by-count":47,"title":["Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis"],"prefix":"10.2106","volume":"99","author":[{"given":"Shu-Fen","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation (S.-F.S., I-H.L., Y.-H.C., and C.-L.H.) and Department of Internal Medicine (C.-W.H.), Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan"},{"name":"National Yang-Ming University School of Medicine, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation (S.-F.S., I-H.L., Y.-H.C., and C.-L.H.) and Department of Internal Medicine (C.-W.H.), Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan"},{"name":"National Yang-Ming University School of Medicine, Taipei City, Taiwan"},{"name":"School of Nursing, Fooyin University, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Shyan","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Nursing, Fooyin University, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsiu","family":"Liou","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation (S.-F.S., I-H.L., Y.-H.C., and C.-L.H.) and Department of Internal Medicine (C.-W.H.), Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Han","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation (S.-F.S., I-H.L., Y.-H.C., and C.-L.H.) and Department of Internal Medicine (C.-W.H.), Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation (S.-F.S., I-H.L., Y.-H.C., and C.-L.H.) and Department of Internal Medicine (C.-W.H.), Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"bib2-20230714","first-page":"99","article-title":"The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee","volume":"59","author":"Wu","year":"1997","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)."},{"issue":"2","key":"bib3-20230714","first-page":"67","article-title":"Antalgic effect and clinical tolerability of hyaluronic acid in patients with degenerative diseases of knee cartilage: an outpatient treatment survey","volume":"30","author":"Castellacci","year":"2004","journal-title":"Drugs Exp Clin Res."},{"issue":"2","key":"bib4-20230714","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/ar623","article-title":"Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action","volume":"5","author":"Moreland","year":"2003","journal-title":"Arthritis Res Ther."},{"issue":"9","key":"bib5-20230714","first-page":"421","article-title":"Hyaluronans: is clinical effectiveness dependent on molecular weight?","volume":"35","author":"Vitanzo","year":"2006","journal-title":"Am J Orthop (Belle Mead NJ)."},{"issue":"8","key":"bib6-20230714","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1","article-title":"Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement","volume":"44","author":"Lisignoli","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"3","key":"bib7-20230714","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-157-3-201208070-00473","article-title":"Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis","volume":"157","author":"Rutjes","year":"2012","journal-title":"Ann Intern Med."},{"issue":"9","key":"bib8-20230714","first-page":"577","article-title":"AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition","volume":"21","author":"Brown","year":"2013","journal-title":"J Am Acad Orthop Surg."},{"key":"bib9-20230714","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4137\/CMAMD.S12743","article-title":"US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials","volume":"6","author":"Miller","year":"2013","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord."},{"issue":"24","key":"bib10-20230714","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2106\/JBJS.N.00743","article-title":"Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence","volume":"97","author":"Jevsevar","year":"2015","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"bib11-20230714","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03261884","article-title":"Hyaluronic acid in the treatment of knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy of different products","volume":"26","author":"Colen","year":"2012","journal-title":"BioDrugs."},{"issue":"2","key":"bib12-20230714","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage."},{"issue":"1","key":"bib13-20230714","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ard.2008.094623","article-title":"Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial","volume":"69","author":"Chevalier","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"7889","key":"bib14-20230714","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(74)90884-8","article-title":"Measurement of pain","volume":"2","author":"Huskisson","year":"1974","journal-title":"Lancet."},{"issue":"5","key":"bib15-20230714","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W","article-title":"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties","volume":"45","author":"McConnell","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"12","key":"bib16-20230714","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol."},{"key":"bib17-20230714","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009748709102182","article-title":"Indexes of severity for osteoarthritis of the hip and knee. Validation\u2014value in comparison with other assessment tests","volume":"65","author":"Lequesne","year":"1987","journal-title":"Scand J Rheumatol Suppl."},{"issue":"2","key":"bib18-20230714","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc."},{"issue":"7","key":"bib19-20230714","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ptj\/64.7.1067","article-title":"Decrease in timed balance test scores with aging","volume":"64","author":"Bohannon","year":"1984","journal-title":"Phys Ther."},{"key":"bib20-20230714","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12891-015-0513-6","article-title":"Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial","volume":"16","author":"Petrella","year":"2015","journal-title":"BMC Musculoskelet Disord."},{"issue":"Suppl 10","key":"bib21-20230714","first-page":"S92","article-title":"Prospective randomized trial comparing the efficacy of single 6-ml injection of hylan G-F 20 and hyaluronic acid for primary knee arthritis: a preliminary study","volume":"95","author":"Khanasuk","year":"2012","journal-title":"J Med Assoc Thai."},{"issue":"2","key":"bib22-20230714","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain."},{"issue":"1","key":"bib23-20230714","first-page":"131","article-title":"Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities","volume":"29","author":"Angst","year":"2002","journal-title":"J Rheumatol."},{"issue":"4","key":"bib24-20230714","first-page":"779","article-title":"The algofunctional indices for hip and knee osteoarthritis","volume":"24","author":"Lequesne","year":"1997","journal-title":"J Rheumatol."},{"key":"bib25-20230714","first-page":"10","article-title":"Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review","volume":"39","author":"Peyron","year":"1993","journal-title":"J Rheumatol Suppl."},{"issue":"7","key":"bib26-20230714","first-page":"1311","article-title":"Acute local reactions after intraarticular hylan for osteoarthritis of the knee","volume":"22","author":"Puttick","year":"1995","journal-title":"J Rheumatol."},{"issue":"7","key":"bib27-20230714","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2106\/00004623-200207000-00008","article-title":"Granulomatous inflammation after hylan G-F 20 viscosupplementation of the knee : a report of six cases","volume":"84","author":"Chen","year":"2002","journal-title":"J Bone Joint Surg Am."},{"issue":"9","key":"bib28-20230714","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2106\/00004623-200209000-00015","article-title":"Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment","volume":"84","author":"Leopold","year":"2002","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"bib29-20230714","first-page":"327","article-title":"Efficacy and safety of hylan G-F 20 injection in treatment of knee osteoarthritis in Chinese patients: results of a prospective, multicentre, longitudinal study","volume":"21","author":"Yan","year":"2015","journal-title":"Hong Kong Med J."},{"issue":"11","key":"bib30-20230714","first-page":"2203","article-title":"Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial","volume":"25","author":"Altman","year":"1998","journal-title":"J Rheumatol."},{"issue":"2","key":"bib32-20230714","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0968-0160(01)00075-8","article-title":"Is there a place for intra-articular hyaluronate in osteoarthritis of the knee?","volume":"8","author":"Kirwan","year":"2001","journal-title":"Knee."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201703150-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:38:34Z","timestamp":1787751514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201703150-00003"}},"subtitle":["A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety"],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.16.00469","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}